John Moriarty's Trading History
| KARDKardigan, Inc. | Jun 22, 2026 | Chief Legal Officer | Uninformative Buy | ― | $675.19K | |
| RNAMAvidity Biosciences | Feb 27, 2026 | ― | Uninformative Sell | ― | $0.00 | |
| MRTXMirati Therapeutics | Jan 23, 2024 | ― | Uninformative Sell | ― | $0.00 | |
| PTLAPortola Pharma | Jul 02, 2020 | ― | Uninformative Sell | 232.07K | $0.00 | |
| ALXNAlexion Pharmaceuticals | Feb 08, 2018 | ― | Uninformative Buy | ― | $13.60M | |
| OLMAOlema Pharmaceuticals | ― | EVP, Ch. Legal Officer & Sec. | ― | ― |
You May Also Like
John Moriarty insider profile FAQ
What is the percentage of profitable transactions made by John Moriarty?
The percentage of profitable transactions made by John Moriarty is 74%.
What is the average return per transaction made by John Moriarty?
The average return per transaction made by John Moriarty is 12.00%.
What stocks does John Moriarty hold?
John Moriarty holds: KARD, ALXN, PTLA, MRTX, RNAM, OLMA stocks.
What was John Moriarty's most profitable transaction?
John Moriarty’s most profitable transaction was an Informative Sell of ALXN stock on December 15, 2015. The return on the trade was 37.30%.
What is John Moriarty's role in Kardigan, Inc.?
John Moriarty's role in Kardigan, Inc. is Chief Legal Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.